Number of the records: 1
Enhanced International Prognostic Index (NCCN-IPI), Charlson Comorbidity Index and absolute lymphocyte count as predictors for survival of elderly patients with diffuse large B cell lymphoma treated by immunochemotherapy
SYS 0118888 LBL 00000naa^^22^^^^^^^^450 005 20160113092158.4 100 $a 20151209a2015 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Enhanced International Prognostic Index (NCCN-IPI), Charlson Comorbidity Index and absolute lymphocyte count as predictors for survival of elderly patients with diffuse large B cell lymphoma treated by immunochemotherapy $f J. Jelicic ... [et al.] 215 $c ilustr., obr., tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0118585 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 62, no. 6 (2015), s. 988-995 $1 210 $a Bratislava $c AEPress $d 2015 $1 215 $a s. 841-1006 541 1-
$a Rozšírený medzinárodný prognostický index (NCCN-IPI), Charlsonov index komorbidity a absolútny počet lymfocytov ako prediktory pre prežívanie starších pacientov s veľkobunkovým difúznym lymfómom z B-buniek liečeným imunochemoterapiou $z slo 606 1-
$3 sllk_un_auth*d016403 $a lymfóm veľkobunkový difúzny, z B-buniek $x farmakoterapia $x krv $x úmrtnosť $2 mesh 606 1-
$3 sllk_un_auth*d015897 $a komorbidita $2 mesh 606 2-
$3 sllk_un_auth*d007958 $a počet leukocytov $2 mesh 606 2-
$3 sllk_un_auth*d018655 $a počet lymfocytov $2 mesh 606 2-
$3 sllk_un_auth*d000971 $a protokoly kombinovanej protinádorovej chemoterapie $2 mesh 606 1-
$3 sllk_un_auth*d011379 $a prognóza $2 mesh 606 2-
$3 sllk_un_auth*d016019 $a analýza prežívania $2 mesh 606 2-
$3 sllk_un_auth*d018572 $a prežívanie bez choroby $2 mesh 606 2-
$3 sllk_un_auth*d000368 $a ľudia vyššieho veku $9 C $2 mesh 701 -1
$3 sllk_un_auth*0037975 $a Jeličić $b J. $p Clinic of hematology, Clinical Centre of Serbia $4 070 801 -0
$a SK $b BA006 $c 20151209 $g AACR2
Number of the records: 1